Vorsprung durch Technik: Evolution, implementation, QA and safety of new technology in radiotherapy

Radiotherapy and Oncology

Volumn 94, Issue 2, 2010, Pages 125-128

  Thwaites, David I ^a   Verellen, Dirk ^b  

^a ST JAMES S INSTITUTE OF ONCOLOGY   (United Kingdom)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CONE BEAM COMPUTED TOMOGRAPHY; EDITORIAL; EVIDENCE BASED PRACTICE; HUMAN; IMAGING; INTENSITY MODULATED RADIATION THERAPY; MEDICAL INFORMATION; MONITORING; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RADIATION DOSE DISTRIBUTION; RADIOBIOLOGY; RISK ASSESSMENT; TOTAL QUALITY MANAGEMENT; TREATMENT PLANNING;

EQUIPMENT SAFETY; HUMANS; QUALITY ASSURANCE, HEALTH CARE; RADIATION ONCOLOGY;

EID: 77249170180     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.02.004     Document Type: Editorial

References (84)

1. 10th Biennial ESTRO conference on physics and technology for clinical radiotherapy, Aug 30-Sep 3, 2009. Radiother Oncol 2009;92:(Suppl. 1).
2. Nystrom H., and Thwaites D.I. Physics and high-technology advances in radiotherapy: are they still worth it?. Radiother Oncol 86 (2008) 1-3
3. Rodemann H.P. Molecular radiation biology: perspectives for radiation oncology. Radiother Oncol 92 (2009) 293-298
4. MacManus M., Nestle U., Rosenzweig K.E., et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol 9 (2009) 85-94
5. Lavrenkov K., Singh S., Christian J.A., et al. Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning study. Radiother Oncol 91 (2009) 349-352
6. Rosewall T., Kong V., Vesprini D., et al. Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses. Radiother Oncol 90 (2009) 325-330
7. Vilarino-Varela M.J., Taylor A., Rockall A.G., et al. A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging. Radiother Oncol 89 (2008) 92-96
8. van Loon J., Offermann C., Bosmans G., et al. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study. Radiother Oncol 87 (2008) 49-54
9. Schinagl D.A., Hoffmann A.L., Vogel W.V., et al. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?. Radiother Oncol 91 (2009) 95-100
10. van Baardwijk A., Bosmans G., van Suylen R.J., et al. Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study. Radiother Oncol 87 (2008) 55-58
11. Aerts H.J., van Baardwijk A.A., Petit S.F., et al. Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. Radiother Oncol 91 (2009) 386-392
12. Abramyuk A., Tokalov S., Zophel K., et al. Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?. Radiother Oncol 91 (2009) 399-404
13. Fenoglietto P., Laliberte B., Allaw A., et al. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk. Radiother Oncol 88 (2008) 77-87
14. Fenkell L., Kaminsky I., Breen S., et al. Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol 89 (2008) 287-291
15. St-Hilaire J., Sevigny C., Beaulieu F., et al. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients. Radiother Oncol 91 (2009) 342-348
16. Yaparpalvi R., Hong L., Mah D., et al. ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription. Radiother Oncol 89 (2008) 347-352
17. Moon S.H., Shin K.H., Kim T.H., et al. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiother Oncol 90 (2009) 66-73
18. Lee T.F., Fang F.M., Chao P.J., et al. Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma. Radiother Oncol 89 (2008) 89-96
19. Sterzing F., Sroka-Perez G., Schubert K., et al. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-shoot IMRT. Radiother Oncol 86 (2008) 251-257
20. Caudrelier J.M., Morgan S.C., Montgomery L., et al. Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: dosimetric evaluation. Radiother Oncol 90 (2009) 99-105
21. Cattaneo G.M., Dell'oca I., Broggi S., et al. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC. Radiother Oncol 88 (2008) 310-318
22. Iori M., Cattaneo G.M., Cagni E., et al. Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours. Radiother Oncol 88 (2008) 34-45
23. Cozzi L., Dinshaw K.A., Shrivastava S.K., et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 89 (2008) 180-191
24. Fogliata A., Clivio A., Nicolini G., et al. Intensity modulation with photons for benign intracranial tumours: a planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiother Oncol 89 (2008) 254-262
25. Verbakel W.F., Senan S., Cuijpers J.P., et al. Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol 93 (2009) 122-124
26. Clivio A., Fogliata A., Franzetti-Pellanda A., et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: a treatment planning comparison with fixed field IMRT. Radiother Oncol 92 (2009) 118-124
27. Guckenberger M., Richter A., Krieger T., et al. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?. Radiother Oncol 93 (2009) 259-265
28. Wolff D., Stieler F., Welzel G., et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 93 (2009) 226-233
29. Wagner D., Christiansen H., Wolff H., et al. Radiotherapy of malignant gliomas: comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. Radiother Oncol 93 (2009) 593-596
30. Thorwarth D., Soukup M., and Alber M. Dose painting with IMPT helical tomotherapy and IMXT: a dosimetric comparison. Radiother Oncol 86 (2008) 30-34
31. Georg D., Hillbrand M., Stock M., et al. Can protons improve SBRT for lung lesions? Dosimetric considerations. Radiother Oncol 88 (2008) 368-375
32. Widesott L., Amichetti M., and Schwarz M. Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review. Radiother Oncol 86 (2008) 154-164
33. Hillbrand M., Georg D., Gadner H., et al. Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy. Radiother Oncol 89 (2008) 141-149
34. Verellen D., De Ridder M., and Storme G.A. (Short) History of image-guided radiotherapy. Radiother Oncol 86 (2008) 4-13
35. Korreman S., Rasch C., McNair H., et al. The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: A practical and technical review and guide. Radiother Oncol 94 (2010) 129-144
36. Lagendijk J.J., Raaymakers B.W., Raaijmakers A.J., et al. MRI/linac integration. Radiother Oncol 86 (2008) 25-29
37. Stutzel J., Oelfke U., and Nill S. A quantitative image quality comparison of four different image guided radiotherapy devices. Radiother Oncol 86 (2008) 20-24
38. Calcerrada Diaz-Santos N., Blasco Amaro J.A., Cardiel G.A., et al. The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: a systematic review of the literature. Radiother Oncol 89 (2008) 245-253
39. Guckenberger M., Krieger T., Richter A., et al. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol 9 (2009) 288-295
40. Castadot P., Lee J.A., Parraga A., et al. Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors. Radiother Oncol 89 (2008) 1-12
41. Schulze D., Liang J., Yan D., et al. Comparison of various online IGRT strategies: the benefits of online treatment plan re-optimization. Radiother Oncol 90 (2009) 367-376
42. van Haaren P.M., Bel A., Hofman P., et al. Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients. Radiother Oncol 90 (2009) 291-298
43. Zeng G.G., Breen S.L., Bayley A., et al. A method to analyze the cord geometrical uncertainties during head and neck radiation therapy using cone beam CT. Radiother Oncol 90 (2009) 228-230
44. van de Bunt L., Jurgenliemk-Schulz I.M., de Kort G.A., et al. Motion and deformation of the target volumes during IMRT for cervical cancer: what margins do we need?. Radiother Oncol 88 (2008) 233-240
45. Wang L., Hayes S., Paskalev K., et al. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage. Radiother Oncol 91 (2009) 314-324
46. Ehler E.D., and Tome W.A. Lung 4D-IMRT treatment planning: an evaluation of three methods applied to four-dimensional data sets. Radiother Oncol 88 (2008) 319-325
47. Admiraal M.A., Schuring D., and Hurkmans C.W. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume. Radiother Oncol 86 (2008) 55-60
48. McDermott L.N., Wendling M., Nijkamp J., et al. 3D in vivo dose verification of entire hypo-fractionated IMRT treatments using an EPID and cone-beam CT. Radiother Oncol 86 (2008) 35-42
49. Pawlicki T., Yoo S., Court L.E., et al. Moving from IMRT QA measurements toward independent computer calculations using control charts. Radiother Oncol 89 (2008) 330-337
50. Wagner D., Anton M., Vorwerk H., et al. In vivo alanine/electron spin resonance (ESR) dosimetry in radiotherapy of prostate cancer: a feasibility study. Radiother Oncol 88 (2008) 140-147
51. Reynders T., Tournel K., De Coninck P., et al. Dosimetric assessment of static and helical TomoTherapy in the clinical implementation of breast cancer treatments. Radiother Oncol 93 (2009) 71-79
52. Potter R. Image-guided brachytherapy sets benchmarks in advanced radiotherapy. Radiother Oncol 91 (2009) 141-146
53. Sims R., Isambert A., Gregoire V., et al. A pre-clinical assessment of an atlas-based automatic segmentation tool for the head and neck. Radiother Oncol 93 (2009) 474-478
54. Morgan A.M., Knoos T., McNee S.G., et al. Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments. Radiother Oncol 86 (2008) 48-54
55. Huyskens D.P., Maingon P., Vanuytsel L., et al. A qualitative and a quantitative analysis of an auto-segmentation module for prostate cancer. Radiother Oncol 90 (2009) 337-345
56. Pooler A.M., Mayles H.M., Naismith O.F., et al. Evaluation of margining algorithms in commercial treatment planning systems. Radiother Oncol 86 (2008) 43-47
57. Fotina I., Winkler P., Kunzler T., et al. Advanced kernel methods vs. Monte Carlo-based dose calculation for high energy photon beams. Radiother Oncol 93 (2009) 645-653
58. Widesott L., Amichetti M., and Schwarz M. Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review. Radiother Oncol (2008) 86154-86164
59. Ghadjar P., Matzinger O., Isaak B., et al. Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. Radiother Oncol 91 (2009) 237-242
60. Rose J., Rodrigues G., Yaremko B., et al. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol 91 (2009) 282-287
61. Fonteyne V., Villeirs G., Lumen N., et al. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer. Radiother Oncol 92 (2009) 42-47
62. Baumann M., Zips D., and Appold S. Radiotherapy of lung cancer: technology meets biology meets multidisciplinarity. Radiother Oncol 91 (2009) 279-281
63. AAPM task group 40 report, Comprehensive QA for radiation oncology. Med Phys 1994;21:518-618.
64. Department of Health (UK). Quality assurance in radiotherapy: a quality management system for radiotherapy. 1994 PL/CMO(94). London:DH.
65. Thwaites D., Scalliet P., Leer J.W., et al. Quality assurance in radiotherapy. European Society for Therapeutic Radiology and Oncology Advisory Report to the Commission of the European Union for the 'Europe Against Cancer Programme'. Radiother Oncol 35 (1995) 61-73
66. Williamson J.F., Dunscombe P.B., Sharpe M.B., et al. Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on 'quality assurance of radiation therapy: challenges of advanced technology'. Int J Radiat Oncol Biol Phys 71 Suppl. 1 (2008) 2-12
67. IAEA. Comprehensive audits of radiotherapy practices: a tool for quality improvement. 2007, STI/PUB/1297. Vienna:IAEA. www.iaea.org.
68. Palta J.R., Liu C., and Li J.G. Current external beam radiation therapy quality assurance guidance. Does it meet the challenges of emerging image-guided technologies?. Int J Radiat Oncol Biol Phys 71 Suppl. 1 (2008) 13-17
69. Ekaette E., Lee R.C., Cooke D.L., et al. Probabilistic fault tree analysis of a radiation treatment system. Risk Anal 27 (2007) 1395-1410
70. Ford E.C., Gaudette R., Myers L., et al. Evaluation of safety in a radiation oncology setting using failure mode and effects analysis. Int J Radiat Oncol Biol Phys 74 (2009) 852-858
71. Scorsetti M, Signori C, Lattuada P, et al. Applying failure mode effects and criticality analysis in radiotherapy: lessons learned and perspectives of enhancement. Radiother Oncol 2010; doi:10.1016/j.rodonc.2009.12.040.
72. IPEM report 92. Balancing costs and benefits of checking in radiotherapy. 2006. York:IPEM. www.ipem.ac.uk.
73. RCR,SCoR,IPEM,NPSA,BIR. Towards safer radiotherapy. 2008 London: the Royal College of Radiologists. www.rcr.ac.uk.
74. Huq M.S., Fraass B.A., Dunscombe P.B., et al. A method for evaluating quality assurance needs in radiation therapy. Int J Radiat Oncol Biol Phys 71 Suppl. 1 (2008) 170-173
75. Abdel-Wahab M., Rengan R., Curran B., et al. Integrating the healthcare enterprise in radiation oncology plug and play - the future of radiation oncology. Int J Radiat Oncol Biol Phys 76 (2010) 333-336
76. Ibbott G.S., Followill D.S., Molineau H.A., et al. Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials. Int J Radiat Oncol Biol Phys 71 Suppl. 1 (2008) 71-75
77. Johansson K.A., Nilsson P., Zackrisson B., et al. The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRT. Radiother Oncol 87 (2008) 290-299
78. Clark C.H., Hansen V.N., Chantler H., et al. Dosimetry audit for a multi-centre IMRT head and neck trial. Radiother Oncol 93 (2009) 102-108
79. Scalliet P. Risk, society and system failure. Radiother Oncol 80 (2006) 275-281
80. Shafiq J., Barton M., Noble D., et al. An international review of patient safety measures in radiotherapy practice. Radiother Oncol 92 (2009) 15-21
81. Fraass B.A. Errors in radiotherapy: motivation for development of new radiotherapy quality assurance paradigms. Int J Radiat Oncol Biol Phys 71 Suppl. 1 (2008) 162-165
82. Radiation Oncology Safety Information System, available at www.clin.radfys.lu.se.
83. Munro A.J. Hidden danger, obvious opportunity: error and risk in the management of cancer. Br J Radiol 80 (2007) 955-966
84. Norlund A. Costs of radiotherapy. Acta Oncol 42 (2003) 411-415